(Q41656936)

6 October 2017

1 reference

title

Olanzapine: a new antipsychotic agent with efficacy in the management of schizophrenia (English)

1 reference

6 October 2017

1 reference

J C Kando

1

1 reference

6 October 2017

J C Shepski

2

1 reference

6 October 2017

W Satterlee

3

1 reference

6 October 2017

J K Patel

4

1 reference

6 October 2017

S G Reams

5

1 reference

6 October 2017

A I Green

6

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

Annals of Pharmacotherapy

6 October 2017

published in

1 reference

6 October 2017

volume

31

1 reference

6 October 2017

issue

11

1 reference

6 October 2017

page(s)

1325-1334

1 reference

Treatment and the Course of Schizophrenia*

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Clozapine. A novel antipsychotic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Risperidone: review and assessment of its role in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Seroquel: biochemical profile of a potential atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

The glutamatergic dysfunction hypothesis for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Risperidone in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Patient response and resource management: another view of clozapine treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

21 January 2018

Clozapine and seizures

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

Clozapine-related seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101110

10.1177/106002809703101110

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference